This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Get weekly fast money earning schedule tips to help you stay organized and maximize your income. Start earning effectively today.
14,945 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Micron stock has surged dramatically, but savvy investors are asking: is it still a bargain? This article breaks down...
Unanimity in board votes can mask risk. A fresh comparison to avalanche safety training shows why dissent matters for...
Canadian traders face a fast-moving market in May 2026 as platforms race to lower costs and boost real-time data. Thi...
Houlihan Lawrence has named Vicki D’Agostino to head its Scarsdale office, a move aimed at strengthening its luxury r...
Two senior researchers depart the Ethereum Foundation, intensifying leadership churn. Market watchers split on whethe...
A major fund recently disclosed a sizable sale of an AI marketing stock, a move that coincides with a 37% surge in th...
Agora's API-driven platform powers live video, voice, and real-time engagement for apps worldwide. This deep dive exa...
Solana is back in the spotlight as network upgrades and institutional interest pick up. The big question for investor...
Is chewy stock undervalued stock a buy today? This in-depth analysis weighs growth prospects, margins, and risks in a...
As Anthropic prepares an IPO, history warns that sky-high private valuations rarely translate into smooth public-mark...
When Anthropic faced a backlash over secret censorship in Claude Fable 5, the company apologized and promised safegua...